1. Circulating mitochondrial stress 70 protein/mortalin and cytosolic Hsp70 in blood: Risk indicators in colorectal cancer. Issue 11 (21st August 2017) Authors: Jubran, Ritta; Kocsis, Judit; Garam, Nóra; Maláti, Éva; Gombos, Tímea; Barabás, Loránd; Gráf, László; Prohászka, Zoltán; Fishelson, Zvi Journal: International journal of cancer Issue: Volume 141:Issue 11(2017:Dec. 01) Page Start: 2329 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical Results and Biomarker Analyses of Axitinib and TRC105 versus Axitinib Alone in Patients with Advanced or Metastatic Renal Cell Carcinoma (TRAXAR). (29th April 2021) Authors: Choueiri, Toni K.; Zakharia, Yousef; Pal, Sumanta; Kocsis, Judit; Pachynski, Russell; Poprach, Alexandr; Nixon, Andrew B.; Liu, Yingmiao; Starr, Mark; Lyu, Jing; Owzar, Kouros; deShazo, Mollie; Lara, Primo; Geczi, Lajos; Ho, Thai H.; Walsh, Meghara; Adams, Bonne; Robertson, Liz; Darif, Mohamed; T... Journal: Oncologist Issue: Volume 26:Number 7(2021) Page Start: 560 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Elevated levels of mitochondrial mortalin and cytosolic HSP70 in blood as risk factors in patients with colorectal cancer. Issue 2 (12th February 2013) Authors: Rozenberg, Perri; Kocsis, Judit; Saar, Moran; Prohászka, Zoltán; Füst, George; Fishelson, Zvi Journal: International journal of cancer Issue: Volume 133:Issue 2(2013:Jul. 15) Page Start: 514 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 study. Issue 2 (February 2017) Authors: Hickish, Tamas; Andre, Thierry; Wyrwicz, Lucjan; Saunders, Mark; Sarosiek, Tomasz; Kocsis, Judit; Nemecek, Radim; Rogowski, Wojciech; Lesniewski-Kmak, Krzysztof; Petruzelka, Lubos; Apte, Ron N; Mohanty, Prasant; Stecher, Michael; Simard, John; de Gramont, Aimery Journal: Lancet oncology Issue: Volume 18:Issue 2(2017:Feb.) Page Start: 192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial. Issue 3 (March 2019) Authors: Luft, Alexander V.; Karaseva, Nina A.; Kowalyszyn, Rubén Dario; Hernandez, Carlos Alberto; Csoszi, Tibor; De Vita, Ferdinando; Pfeiffer, Per; Sugimoto, Naotoshi; Kocsis, Judit; Csilla, Andràs; Bodoky, Gyorgy; Garnica Jaliffe, Georgina; Protsenko, Svetlana; Madi, Ayman; Wojcik, Elzbieta; Brenner, ... Journal: Lancet oncology Issue: Volume 20:Issue 3(2019) Page Start: 420 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗